Medical Digest & Congress Report
Episodes
Do overweight and obesity confer an additional risk of CAD in patients with FH? - report from EAS2023
02 Jun 2023
Contributed by Lukas
Professor Amany Elshorbagy explains, that obese children and adults with heterozygous familial hypercholesterolemia have a higher risk of coronary art...
Objective assessement of skin disease severity with the help of AI
26 May 2023
Contributed by Lukas
Dr. Maksym Breslavets, Medical Director of Centre for Medical and Surgical Dermatology in Canada explains how artificial intelligence application may ...
What's new in treatment of breast cancer? - Highlights of ESMO BC 2023
24 May 2023
Contributed by Lukas
Prof. Matteo Lambertini explains the highlights of the 2023 ESMO Breast Cancer Conference. - There are more insights of the toxicity of the new ACD&#...
Hot topics in melanoma management - report from EADO2023
15 May 2023
Contributed by Lukas
We asked Professor Paolo Ascierto, world known expert in the field of skin cancer treatment about hot topics in melanoma management. Based on the curr...
Functional Precision Medicine in Oncology - report from AACR2023
04 May 2023
Contributed by Lukas
Professor Anthony Letai, President of the Society for Functional Precision Medicine explains the concept of functional precision medicine in oncology:...
The first mRNA cancer vaccine with pembrolizumab minimizes recurrence rate in melanoma tells Jeffrey Weber clinical investigator - report from AACR2023
28 Apr 2023
Contributed by Lukas
Jeffrey Weber explains the efficacy and safety results from the randomized, open-label Phase 2 mRNA-4157-P201/Keynote-942 trial presented at ACCR 2023...
Current issues in the treatment of schizophrenia - report from EPA2023
12 Apr 2023
Contributed by Lukas
Professor Istvan Bitter from Semmelweis University, Budapest, Hungary is sharing his insights on schizophrenia treatment. In the last decades numerous...
Highlights of EPA 2023 - report from EPA2023
06 Apr 2023
Contributed by Lukas
Professor Peter Falkai, past president of the European Psychiatric Association, is sharing his insights on the EPA 2023 Congress, guided by the motto ...
The Risk of Early Recurrent MI: What is the Role of Cholesterol Efflux and ApoA-I? - report from ACC2023
04 Apr 2023
Contributed by Lukas
Prosessor Eliot A. Brinton on the risk and incidence of recurrent CV events post-AMI, and the role of cholesterol efflux and ApoA-I in plaque stabiliz...
Bempedoic Acid Improves Cardiovascular Outcomes In Statin Intolerant Patients At High Cardiovascular Risk - report from ACC2023
31 Mar 2023
Contributed by Lukas
Prosessor Eliot A. Brinton explains the results of the CLEAR Outcomes trial, the first study to assess whether bempedoic acid could reduce cardiovascu...
How to increase prescription of evidence-based therapies in adults with T2D and ASCVD? - The COORDINATE-Diabetes Study - report from ACC2023
29 Mar 2023
Contributed by Lukas
Dr. Neha Pagidipati presented the COORDINATE-Diabetes Study's primary results. Evidence-based therapies are under-used in clinical practice, and t...
The FREEDOM COVID Anticoagulation Strategy Randomized Trial - report from ACC2023
28 Mar 2023
Contributed by Lukas
Professor Gregg Stone explains the results of the FREEDOM COVID Anticoagulation Strategy Randomized Trial. The main conclusions are among non-critical...
Minimally Invasive Versus Conventional Sternotomy For Mitral Valve Repair Surgery - UK Mini Mitral Trial - report from ACC2023
27 Mar 2023
Contributed by Lukas
Professor Enoch Akowuah explains the results of the UK Mini Mitral Trial. The best surgical approach for mitral valve repair is widely debated. The tr...
Can Patients with Hypertrophic Cardiomyopathy do Vigorous Exercise? - A Multinational Lifestyle And Exercise Study - report from ACC2023
22 Mar 2023
Contributed by Lukas
Professor Rachel Lampert explains the findings of LIVE-HCM trial presented at ACC.23/WCC: patients with hypertrophic cardiomyopathy who exercised vigo...
Efficacy and Safety of Oral PCSK9 Inhibitor, MK-0616 in the Treatment of Hypercholesterolemia - report from ACC2023
21 Mar 2023
Contributed by Lukas
Professor Eliot Brinton, the President, Utah Lipid Center, Salt Lake City explains the results of the research led by Professor Christie Ballantyne, t...
Transcatheter Edge-to-Edge Repair of Functional Mitral Regurgitation in Heart Failure - The COAPT Trial - report from ACC2023
20 Mar 2023
Contributed by Lukas
Professor Gregg Stone explains details on the COAPT trial which set out to assess the safety and efficacy of transcatheter mitral leaflet approximatio...
Elevated Lipoprotein(a) as a Risk Enhancing Factor for Atherosclerotic Cardiovascular Disease - report from ACC2023
16 Mar 2023
Contributed by Lukas
Searching for potential cardiovascular risk factors led to many discoveries in the last decades and radically changed our view on CV prevention. Profe...
Sotatercept in combination with background therapy for the treatment of Pulmonary Arterial Hypertension — STELLAR Trial - report from ACC2023
14 Mar 2023
Contributed by Lukas
Professor Marius Hoeper explains the results of a phase 3 trial of sotatercept for treatment of Pulmonary Arterial Hypertension. The conclusion is tha...
The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA - report from ACC2023
10 Mar 2023
Contributed by Lukas
Professor Eliot A. Brinton talks about a new development about the use of Omega-3 fatty acids at the American College of Cardiology and World Congress...
LMWH use in pregnancy: The Highlow and the ALPINE trial - report from ASH2022
10 Jan 2023
Contributed by Lukas
Professor Saskia Middeldorp talks about two very important trails were published on LMWH use in pregnancy in 2022. The first one is the Highlow study ...
Treatment options for early, HR+, HER2- Breast Cancer - report from SABCS2022
10 Jan 2023
Contributed by Lukas
Professor Hope Rugo were speaker and co-author of several presentations at this years San Antonio Breast Cancer Symposium. We asked her about early st...
Post neoadjuvant therapy in Triple Negative Breast Cancer - report from SABCS2022
10 Jan 2023
Contributed by Lukas
Professor Hope Rugo were speaker and co-author of several presentations at this years San Antonio Breast Cancer Symposium. We asked her about triple n...
Highlights of the San Antonio Breast Cancer Symposium 2022 - report from SABCS2022
15 Dec 2022
Contributed by Lukas
Professor Virginia Kaklamani speak about the novelties and state of the art treatment presented at SABCS 2022. (DESTINY-Breast02 trial Trastuzumab Der...
Targeting CV risk factors with GLP-1 RAs in people with obesity - report from EASD2022
18 Oct 2022
Contributed by Lukas
Professor Michael Lincoff shares with us a discussion occurred during the EASD 2022 meeting, this was focusing on the modification of cardiovascular r...
Once weekly insulin: The ONWARDS 2 study - report from EASD2022
13 Oct 2022
Contributed by Lukas
Professor Tina Vilsbøll chaired a very interesting session looking into once weekly insulin. Video: https://congressreport.eu/scientific-contents/int...
Is HFpEF hiding in your practice? Key messages of the DELIVER study: Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction - report from EASD2022
12 Oct 2022
Contributed by Lukas
We asked Professor Silvio Inzucchi about the key messages of the DELIVER study, he talked about this topic at the recent EASD 2022. Video: https://con...
Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg - report from EASD2022
11 Oct 2022
Contributed by Lukas
Domenica Rubino, Director of Washington Center for Weight Management & Research at Arlington, Virginia, USA, held a very interesting lecture about...
Semaglutide 2.4 mg reduces the 10-year type 2 diabetes risk in people with overweight or obesity - report from EASD2022
11 Oct 2022
Contributed by Lukas
Professor Timothy Garvey, Director of Diabetes Research Center at University of Alabama presented new data from the STEP trial program at this year EA...
Let’s talk about CGM evidence: Using basal insulins in T1D in daily life and when exercising - report from EASD2022
05 Oct 2022
Contributed by Lukas
Continuous glucose monitoring gives us the opportunity to better analyze diabetes. The new insights help us to improve the therapy of our patients in ...
Primary results of the phase 3 KEYNOTE-412 study - report from ESMO2022
05 Oct 2022
Contributed by Lukas
Professor Jean-Pascal Machiels Head of the Department of Medical Oncology at the Cliniques Universitaires Sain-Luc, Brussels, presented results of the...
Treatment with tumor-infiltrating lymphocytes versus ipilimumab for advanced melanoma - report from ESMO2022
29 Sep 2022
Contributed by Lukas
Professor John Haanen from the Netherlands Cancer Institute presented the first randomized phase 3 trial on treatment with tumor-infiltrating lymphocy...
Effect of liraglutide on muscle fat infiltration in adults with overweight or obesity - report from EASD2022
28 Sep 2022
Contributed by Lukas
Professor Ambarish Pandey presented the results a randomised clinical trial about the effect of liraglutide on muscle fat infiltration in overweight o...
The IPSOS trial - report from ESMO2022
23 Sep 2022
Contributed by Lukas
Siow Ming Lee, Professor of Medical Oncology at University College London, presented the results of the IPSOS trial at the ESMO 2022 Congress. This wa...
Choices in asthma and COPD care: How to maximize outcomes for patients - report from ERS2022
19 Sep 2022
Contributed by Lukas
Professor Charlotte Suppli Ulrik took part in a very interesting session at this years ERS congress on how to maximize patients outcome in asthma and ...
A fresh look at pulmonary hypertension: practical takeaways for patient management - report from ESC2022
13 Sep 2022
Contributed by Lukas
Dr John Coghlan going to share his insights with us on evidence - based treatment decisions in pulmonary arterial hypertension. Video: https://co...
Influenza Vaccine Among Patients with Acute Coronary Syndromes: the VIP-ACS trial - report from ESC2022
12 Sep 2022
Contributed by Lukas
Professor Remo Furtado had an important presentation on the Influenza Vaccine among patients with Acute Coronary Syndromes at this year’s ESC Congre...
Facing anticoagulation dilemmas in venous thromboembolism - report from ESC2022
12 Sep 2022
Contributed by Lukas
Professor Ingrid Pabinger held a presentation on extended anticoagulation in venous thromboembolism at the recent ESC Congress in Barcelona. We asked ...
The importance of optimal RAASi therapy in heart failure - report from ESC2022
08 Sep 2022
Contributed by Lukas
Professor Dan Atar had an important presentation on the importance of optimal RAASi therapy in heart failure at this year’s ESC Congress. He is goin...
Chronic coronary syndrome: re-thinking treatment management and outcome priorities - report from ESC2022
07 Sep 2022
Contributed by Lukas
Professor Athanasios J. Manolis chaired a very eye-opening session on how to improve care in patients with chronic coronry syndrome at this years ESC ...
Dual antiplatelet therapy in practice - report from ESC2022
06 Sep 2022
Contributed by Lukas
Professor Roxana Mehran chaired a very special Guidelines in Practice session at this year’s ESC Congress on dual antiplatelet therapy. We asked her...
2022 ESC-ERS Guidelines for the diagnosis and treatment of pulmonary hypertension - report from ESC2022
05 Sep 2022
Contributed by Lukas
Professor Marion Delcroix co-chareid the session presenting the 2022 ESC-ERS guideline for the diagnosis and treatment of pulmonary hypertension at th...
Guidelines in Practice: management of dyslipidaemias in the elderly - report from ESC2022
05 Sep 2022
Contributed by Lukas
Professor Ricardo Asteggiano chaired a guideline is practice session on the management of dyslipidaemias in the elderly at this years ESC Congress. We...
Guidelines in Practice: dual antiplatelet therapy (DAPT) - report from ESC2022
02 Sep 2022
Contributed by Lukas
Professor Robert Storey co-chaired a very interesting Guidelines in Practice session on dual antiplatelet therapy at this year’s ESC Congress.  ...
Getting to LDL-C goals and staying there long-term - report from ESC2022
01 Sep 2022
Contributed by Lukas
Professor Mamas Mamas chaired a very interesting interactive session at this years ESC Congress in Barcelona. We asked him to share his insights with ...
Cardiorenal benefits of finerenone: protecting the heart and kidneys - report from ESC2022
01 Sep 2022
Contributed by Lukas
Professor George Bakris chaired a very interesting session at the recent ESC Congress on the Cardiorenal benefits of finerenone, which is indicated fo...
The Journey to Address Unmet Needs Across all Haemophilia Indications - report from ISTH2022
29 Jul 2022
Contributed by Lukas
Dr. Maria Elisa Mancuso chaired a symposium at the recent ISTH 2022 congress. The main topic was to try to understand which are the clinical met needs...
Anticoagulant Advancements for VTE in Children - report from ISTH2022
29 Jul 2022
Contributed by Lukas
We asked Professor Heleen van Ommen about a symposium presented on the ISTH 2022 congress in London, which was about pediatric thrombosis. Video: http...
Clinical Challenges in Patients with Venous Thromboembolism - report from ISTH2022
28 Jul 2022
Contributed by Lukas
Professor Walter Ageno shared us his thoughts on a symposium he took part on the recent ISTH 2022 congress, which addressed very practical issues in t...
Good practice statements for antithrombotic therapy in the management of COVID-19 - report from ISTH2022
28 Jul 2022
Contributed by Lukas
Professor Alex Spyropoulos shared with us the guidance statement of the Scientific Standardization Committee of the ISTH about the good practice state...
ISTH Proposal to Standardize Functional Assays in the Diagnosis of Heparin‐induced Thrombocytopenia - report from ISTH2022
27 Jul 2022
Contributed by Lukas
Professor Ishac Nazy held an interesting symposium durint the recent ISTH 2022 congress. He shared us his thought about ISTH proposal to standardize f...
Navigating the Joint Health Journey for Patients With Hemophilia - report from ISTH2022
27 Jul 2022
Contributed by Lukas
Professor Margareth C. Ozelo shared us his thought about a symposium held at the recent ISTH 2022, which topic was about general issues related to joi...
Strategies for Assessing and Managing DOAC-Related Bleeding - report from ISTH2022
26 Jul 2022
Contributed by Lukas
Professor Deborah Siegal chaired an interesting symposium during the ISTH 2022 congress in London, the topic was strategies for assessing and managing...
Approaches to Standardisation and Monitoring for Haemophilia Gene Therapy: Consistency, Considerations and Challenges - report from ISTH2022
26 Jul 2022
Contributed by Lukas
Professor Johnny Mahlangu shared with us a symposium that they organized during the ISTH 2022 congress. They examined approaches to standardisation an...
Comparison between full dose and reduced dose enoxaparin in the management of cancer-associated venous thromboembolism - report from ISTH2022
25 Jul 2022
Contributed by Lukas
We asked Dr. Emma Leitinger about their work which was presented as a poster at the recent ISTH 2022 congress. Video: https://congressreport.eu/scient...
Roles of FVIII in Endothelial Cell Biology: More than a Coagulation Factor? - report from ISTH2022
25 Jul 2022
Contributed by Lukas
We asked Professor Antonia Follenzi about their research data on the role of Factor VIII, what she presented on the recent ISTH 2022 congress in Londo...
Diagnosis and management of primary aldosteronism - report from ESH2022
25 Jul 2022
Contributed by Lukas
Professor Paolo Mulatero co-chaired a Meet the Expert session about the novelties diagnosis and management of primary aldosteronism at the recent ESH ...
Adherence to antihypertensive treatment in patients with CKD: a barrier to optimal renoprotection - report from ISTH2022
22 Jul 2022
Contributed by Lukas
We asked Professor Michel Burnier about the adherence to antihypertensive treatment in patients with CKD, what he presented at the ESH Working Group o...
Brain cancers and the risk of intracranial hemorrhage with DOACs versus Low Molecular Weight Heparin - report from ISTH2022
22 Jul 2022
Contributed by Lukas
We asked Professor Philip Haddad about anticoagulation treatment of patients with brain tumor. Professor Haddad presented a meta-analysis of the use o...
Special forms of hypertension, optomized prevention and hypertension epidemiology - report from ESH2022
22 Jul 2022
Contributed by Lukas
Professor Gianfranco Parati took part in many interesting sessions during the recent European Society of Hypertension. We asked to share his insight o...
“Ten months of needles, we’d better get it right!” - The Highlow Study - report from ISTH2022
21 Jul 2022
Contributed by Lukas
Professor Saskia Middeldorp presented the result of the Highlow Study at the recent ISTH 2022 congress in London, which investigated the different dos...
ISTH Guidelines for Anticoagulation in COVID-19 - report from ISTH2022
21 Jul 2022
Contributed by Lukas
We asked Professor Sam Schulman about the ISTH Guidelines on antithrombotic treatment in COVID-19. Video: https://congressreport.eu/scientific-content...
The SAXOPHONE Study - report from ISTH2022
21 Jul 2022
Contributed by Lukas
We asked Professor Mark R. Payne about the new results of the SAXOPHONE Study what he presented at the recent ISTH 2022 congress. The study inve...
Current Guidelines on Perioperative Anticoagulation Management: DOACs - report from ISTH2022
20 Jul 2022
Contributed by Lukas
DOACs revolutionize the anticoagulation treatment in the last decade, but we have a few open question yet. We asked Professor James Douketis about the...
Diagnosis and management of non-adherence in hypertension treatment - report from ESH2022
14 Jul 2022
Contributed by Lukas
Professor Jan Václavík held a lecture at the recent European Society of Hypertension 2022 Congress about the diagnosis of non-adherence in antihyper...
Implementation of the 2019 lipid guidelines: where are we now? - report from EAS2022
14 Jul 2022
Contributed by Lukas
Professor Alberico L. Catapano spoke about the European Atherosclerosis Society annual meeting, the novelties presented there, the ESC/EAS joint sessi...
Nocturnal hypertension - report from ESH2022
12 Jul 2022
Contributed by Lukas
At the recent European Society of Hypertension 2022 annual congress, nocturnal hypertension addressed as one of the six hot questions in blood pressur...
Blood pressure management in older frail patients - report from ESH2022
11 Jul 2022
Contributed by Lukas
There are long standing debates around the blood pressure lowering treatment in elderly patients. Fortunately more and more clinical trials incl...
Lifelong burden of hypertension - report from ESH2022
08 Jul 2022
Contributed by Lukas
Professor Giuseppe Mancia spoke about a very interesting session from the recent European Society of Hypertension congress in Athens. The session was ...
New pathogenic insights in chronic urticaria - report from EADV Symposium 2022
06 Jul 2022
Contributed by Lukas
Professor Ana Giménez-Arnau chaired a very interesting session about chronic urticaria and the new pathogenic insights about it at the recent EADV sy...
Novelties in the diagnosis and management of primary aldosteronism - report from ESH2022
21 Jun 2022
Contributed by Lukas
Professor Constantine Stratakis co-chaired a meet the expert session at the 31st European Meeting on Hypertension and Cardiovascular Protection....
Results from the phase 3 PARADIGM trial - report from ASCO2022
16 Jun 2022
Contributed by Lukas
Professor Takayuki Yoshino presented at the recent ASCO 2022 new data about the PARADIGM trial. He summerized us the main findings. (Panitumumab plus ...
Detecting elevated lipoprotein(a) and addressing the ASCVD risks - report from EAS2022
16 Jun 2022
Contributed by Lukas
Professor Florian Kronenberg presented the lipoprotein(a) consensus panel recommendations in the recent European Atherosclerosis Society 2022 Congress...
Who needs injectable therapies for cholesterol lowering or statins and ezetimibe are enough for CVD prevention? - report from EAS2022
15 Jun 2022
Contributed by Lukas
Professor Carl Orringer was a co-chair of a recent symposium at the European Atherosclerosis Society 2022 session in Milan. The topic of the discussio...
Pembrolizumab in CRC: What did we learn from the KEYNOTE-177 and the KEYNOTE-651 trials? - report from ASCO2022
15 Jun 2022
Contributed by Lukas
Professor Richard D. Kim presented a data about the long term follow-up of the KEYNOTE-651 study at the recent ASCO 2022 congress. We asked him about ...
The difference between the genetic and pharmacological inhibition of PCSK9 - report from EAS2022
10 Jun 2022
Contributed by Lukas
Professor Giuseppe Danilo Norata discussed in the interview what is difference between PCSK9 genetic deficiency and PCSK9 pharmacological inhibition. ...
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up - interview with Sibylle Loibl
10 Jun 2022
Contributed by Lukas
Professor Sibylle Loibl was the recipient of the 2022 ESMO Breast Cancer award for her excepcional contribution the clinical research of Breast Cancer...
Long-term efficacy and safety of ixekizumab - interview with Andrew Blauvelt
02 Jun 2022
Contributed by Lukas
Dr. Andrew Blauvelt is the first author of a recent paper which analyzes long-term efficacy and safety of ixekizumab in psoriasis. Dr. Blauvelt tell u...
ESC/EAS joint session: What is new in secondary CV prevention?
02 Jun 2022
Contributed by Lukas
Professor Ulrich Laufs talk about a very challenging topic, secondary cardiovascular prevention. At the European Atherosclerosis Society annual meetin...
ESC/EAS joint session: Advances in CV risk estimation with focus on dyslipidemia - report from EAS2022
31 May 2022
Contributed by Lukas
Professor Ian Graham shared us the advances of the cardiovascular risk collaboration he spoke about of the ESC/EAS joint session at EAS 2022. Video: h...
Treatment options of chronic urticaria - report from EADV Symposium 2022
31 May 2022
Contributed by Lukas
Professor Margarida Gonçalo shared with us one of the session of the recent EADV Symposium took place in Ljubljana. The topic was chronic urticaria. ...
Novelties at the International Summit of Lung Cancer in Rome - report from ISLC2022 in Rome
30 May 2022
Contributed by Lukas
Professor Federico Cappuzzo summarize the program of the Summit held in Rome. During the sessions was discussed various aspects in the field of lung c...
Atrial fibrillation guidelines into clinical practice - report from EHRA2022
03 May 2022
Contributed by Lukas
Professor Daniel Scherr co-chaired a very interesting symposium at the recent EHRA 2022 congress, how the can physicians better use the guidelines. We...
Recent developments of the conduction system pacing - report from EHRA2022
29 Apr 2022
Contributed by Lukas
Professor Hung-Fat Tse is an expert on the field on pacing, and recently co-chaired a very interesting symposium at the EHRA 2022 about the recent dev...
What do new guidelines tell us about conduction system pacing? - report from EHRA2022
28 Apr 2022
Contributed by Lukas
Professor Michael Glikson co-chaired the European Society of Cardiology guidelines on cardiac pacing, and now he speaks for us about the part of this ...
Conduction system pacing: ready for prime time? - report from EHRA2022
28 Apr 2022
Contributed by Lukas
Professor Mauro Biffi speak us about the data that were presented at the recent European Heart Rhythm Association meeting. The session he talking abou...
Antithrombotic Approaches to Reduce the Risk of Secondary Event in CAD and PAD - report from ACC2022
22 Apr 2022
Contributed by Lukas
Professor Marc Bonaca co-moderated a session at the American College of Cardiology meeting that was focused on the care of patients with advanced vasc...
Results from the EMPULSE Trial - report from ACC2022
20 Apr 2022
Contributed by Lukas
Professor Mikhail Kosiborod going to speaking about the additional analysis from the EMPULSE trial that were presented at the American College of Card...
Effect of Sotagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes and Moderate Renal Impairment Who Are at Cardiovascular Risk - report from ACC2022
14 Apr 2022
Contributed by Lukas
Professor Deepak Bhatt had presented an analysis from the SCORED trial at the American College of Cardiology Annual Sessions as a late-breaking clinic...
Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment - interview with Federico Cappuzzo
14 Apr 2022
Contributed by Lukas
Professor Federico Cappuzzo gave us an update on the emerging data on the field of lung cancer. There are very important news that were presented duri...
Bentracimab Immediately and Significantly Reverses the Antiplatelet Effects of Ticagrelor in Older People - report from ACC2022
14 Apr 2022
Contributed by Lukas
Professor Deepak Bhatt gave us a brief recap of some data he presented at the ACC Late-Braker session. He presented data about a drug know as Bentraci...
Protecting comorbid patients with atrial fibrillation from stroke - report from EHRA2022
11 Apr 2022
Contributed by Lukas
Professor John Camm recently attended the European Heart Rhythm Association annual congress. One of the session he involved in wanted to group t...
How to reduce limb events including amputations in our patients? - report from ACC2022
08 Apr 2022
Contributed by Lukas
Professor Manesh Patel speak about how to reduce limb events, amputations and making our patients limbs to better with peripheral arterial disease. Vi...
Guidance in Heart Failure Care at ACC 2022 - report from ACC2022
08 Apr 2022
Contributed by Lukas
Professor David Lanfear summarize the key interesting things from the American College of Cardiology 2022 Scientific sessions in the topic. Video: htt...
EHRA scientific documents 2022 - report from EHRA2022
08 Apr 2022
Contributed by Lukas
Professor Cecilia Linde gave us an update from the European Heart Rhythm Association conference from Copenhagen on four topics regarding the EHRA scie...
Updated Cumulative Results of Treatment With Mavacamten From the EXPLORER-LTE Cohort of the MAVA-LTE Study - report from ACC2022
06 Apr 2022
Contributed by Lukas
Professor Florian Rader presented this year at ACC 2022 the results of the MAVA-LTE Study. As the backdrop of this study, Hypertrophic Cardiomyopathy ...
The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma - interview with David F. McDermott
10 Mar 2022
Contributed by Lukas
Prof. David F. McDermott shared his thoughts in the kidney cancer filed. What was the biggest changes in the last six months? Video: https://congressr...
How will the current therapeutic options change the treatment of RCC in the daily practice? - interview with Camillo Porta
10 Mar 2022
Contributed by Lukas
Prof. Camillo Porta shared his thoughts on the ASCO GU 2022 meeting which focused on the renal cell carcinoma updates. Which were those changes what w...
Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma - interview with Stefan N. Symeonides
08 Mar 2022
Contributed by Lukas
Professor Stefan N. Symeonides gave us a talk about the results from 30-month follow-up of KEYNOTE-564. Video: https://congressreport.eu/scientific-co...
Treatment intensification in the treatment of prostate cancer - interview with Oliver Sartor
08 Mar 2022
Contributed by Lukas
Professor Oliver Sartor gave us a talk about the newer concepts around the treatment intensification in prostate cancer, focus a little bit on the new...
First-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer - interview with Ken Kato
01 Mar 2022
Contributed by Lukas
Professor Ken Kato gave us a talk about longer-term efficacy, safety, and quality-of-life results from the phase 3 KEYNOTE-590 study. Video: https://c...